Inventor · disambiguated record
Rongzhao Fu
Also filed as: FU RONGZHAO
17 granted patents·7 pending applications·26 citations·filing 2004–2018
89Inventor score
Files withBONTAC BIO ENG SHENZHEN CO LTD11BONTAC BIO-ENGINEERING (SHENZHEN) CO LTD7GENEHARBOR HK TECHNOLOGIES LTD2WANG JUN2BIORIGHT WORLDWIDE CO LTD1
Top patents by PatentIndex Score
24 records- 0191US10214552B2Method for purifying beta-nicotinamide mononucleotideBONTAC BIO ENG SHENZHEN CO LTD·Filed 2015·Granted Feb 26, 2019·16 cites·9 claims
- 0284US10519429B2Nicotinamide phosphoribosyltransferase (NAMPT) mutant and use thereofBONTAC BIO ENG SHENZHEN CO LTD·Filed 2018·Granted Dec 31, 2019·2 cites·17 claims
- 0384US10174298B2Nicotinamide phosphoribosyltransferase (NAMPT) mutant and use thereofBONTAC BIO ENG SHENZHEN CO LTD·Filed 2016·Granted Jan 8, 2019·2 cites·3 claims
- 0480US7704719B2Glucose isomerase mutants, DNA thereof and use thereofGENEHARBOR HK TECHNOLOGIES LTD·Filed 2006·Granted Apr 27, 2010·4 cites·6 claims
- 0564US7919300B2Glucose isomerase mutantsWANG JUN·Filed 2004·Granted Apr 5, 2011·1 cites·18 claims
- 0658US9950000B2Use of NADH or salt thereof in preparation of drugs or health-care products for treating phenylketonuriaBONTAC BIO ENG SHENZHEN CO LTD·Filed 2017·Granted Apr 24, 2018·0 cites·7 claims
- 0755US8067561B2Isolated DNA encoding recombinant glucose isomeraseWANG JUN·Filed 2010·Granted Nov 29, 2011·0 cites·6 claims
- 0854US11052100B2Stable nicotinamide riboside composition and preparation method thereofBONTAC BIO ENG SHENZHEN CO LTD·Filed 2018·Granted Jul 6, 2021·0 cites·9 claims
- 0954US7858351B2S-adenosylmethionine synthetase mutants, the DNAs encoding the same and uses of the mutantsGENEHARBOR HONG KONG TECHNOLOGIES LTD·Filed 2007·Granted Dec 28, 2010·1 cites·13 claims
- 1051US7923222B2Methods of using isolated glucose isomeraseGENEHARBOR HK TECHNOLOGIES LTD·Filed 2010·Granted Apr 12, 2011·0 cites·8 claims
- 1150US10894059B2NADH compound composition, and preparation and use thereofBONTAC BIO ENG SHENZHEN CO LTD·Filed 2017·Granted Jan 19, 2021·0 cites·9 claims
- 1248US10765967B2Process for purifying NADPHBONTAC BIO ENG SHENZHEN CO LTD·Filed 2016·Granted Sep 8, 2020·0 cites·17 claims
- 1346US8012726B2Method of making bioethanol by using glucose isomerase mutantsBIORIGHT WORLDWIDE CO LTD·Filed 2006·Granted Sep 6, 2011·0 cites·1 claims
- 1445US11312948B2Method and enzyme for preparation of enzyme-modified stevia sugar and use of enzyme-modified stevia sugarBONTAC BIO ENG SHENZHEN CO LTD·Filed 2018·Granted Apr 26, 2022·0 cites·8 claims
- 1544US11040996B2Method for preparing nicotinamide mononucleotide (NMN)BONTAC BIO ENG SHENZHEN CO LTD·Filed 2016·Granted Jun 22, 2021·0 cites·7 claims
- 1644US2017095500A1Use of nadh or salt thereof in preparation of drugs or health-care products for treating phenylketonuriaBONTAC BIO-ENGINEERING (SHENZHEN) CO LTD·Filed 2015·Application pending·0 cites
- 1742US11299721B2Acid phosphatase mutant, use thereof and method for preparing nicotinamide riboside by sameBONTAC BIO ENG SHENZHEN CO LTD·Filed 2018·Granted Apr 12, 2022·0 cites·5 claims
- 1841US2017080011A1Use of nadh and nmn in preparation of drugs or health-care products for treating parkinson's diseaseBONTAC BIO-ENGINEERING (SHENZHEN) CO LTD·Filed 2015·Application pending·0 cites
- 1941US2017266213A1Use of beta-nicotinamide mononucleotide in preparation of anti-aging drugs or health-care productsBONTAC BIO-ENGINEERING (SHENZHEN) CO LTD·Filed 2015·Application pending·0 cites
- 2036US10214556B2Method for purifying reduced form of β-nicotinamide adenine dinucleotideBONTAC BIO ENG SHENZHEN CO LTD·Filed 2015·Granted Feb 26, 2019·0 cites·10 claims
- 2132US2016340378A1Method for purifying oxidized form of beta-nicotinamide adenine dinucleotide phosphateBONTAC BIO-ENGINEERING (SHENZHEN) CO LTD·Filed 2015·Application pending·0 cites
- 2232US2016340377A1Method for purifying oxidized form of beta-nicotinamide adenine dinucleotideBONTAC BIO-ENGINEERING (SHENZHEN) CO LTD·Filed 2015·Application pending·0 cites
- 2327US2017165283A1Use of beta-nicotinamide mononucleotide in preparation of health-care products for preventing and treating arteriosclerosis and cardio-cerebrovascular diseases, and health-care product containing the sameBONTAC BIO-ENGINEERING (SHENZHEN) CO LTD·Filed 2015·Application pending·0 cites
- 2427US2017165282A1Use of beta-nicotinamide mononucleotide in preparation of drugs for preventing and treating arteriosclerosis and cardio-cerebrovascular diseases, and drugs containing the sameBONTAC BIO-ENGINEERING (SHENZHEN) CO LTD·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →